Please select the option that best describes you:
Would you offer other antibody-drug conjugates to a patient who had a history of G2 trastuzumab deruxtecan-induced pneumonitis that is now resolved?
This includes TDM-1, datopotamab deruxtecan, and sacituzumab govitecan